Big Pharma Split Corp (PRM.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Other Working Capital | -12 | 10 | 175 | -154 | -32 |
| Other Operating Activity | 1,723 | 11,849 | 953 | -8,846 | 4,380 |
| Operating Cash Flow | $1,711 | $11,858 | $1,128 | $-9,000 | $4,348 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 351 | 0 | 400 | 7,574 | N/A |
| Common Stock Repurchased | -469 | -5,322 | N/A | N/A | -1,687 |
| Dividend Paid | -2,040 | -2,109 | -2,616 | -2,836 | -1,731 |
| Other Financing Activity | 1,275 | -5,040 | 479 | 5,455 | -1,234 |
| Financing Cash Flow | $-882 | $-12,471 | $-1,737 | $10,194 | $-4,652 |
| Exchange Rate Effect | -2 | -3 | -2 | 5 | -1 |
| Beginning Cash Position | 204 | 819 | 1,430 | 231 | 536 |
| End Cash Position | 1,031 | 204 | 819 | 1,430 | 231 |
| Net Cash Flow | $828 | $-612 | $-609 | $1,193 | $-304 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,711 | 11,858 | 1,128 | -9,000 | 4,348 |
| Free Cash Flow | 1,711 | 11,858 | 1,128 | -9,000 | 4,348 |